XML 61 R49.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Emflaza asset acquisition - Allocation of the purchase consideration (Details) - Marathon Pharmaceuticals, LLC $ in Thousands | Apr. 20, 2017 USD ($)
--- | ---
Finite-Lived Intangible Assets [Line Items] |
Inventory | $ 3,980
Intellectual Property |
Finite-Lived Intangible Assets [Line Items] |
Purchase price | 152,353
Emflaza rights | $ 148,373

X
- Definition Asset Acquisition, Consideration Transferred + References No definition available. + Details
Name: | ptct_AssetAcquisitionConsiderationTransferred
Namespace Prefix: | ptct_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Assets Acquired, Inventory + References No definition available. + Details
Name: | ptct_AssetsAcquiredInventory
Namespace Prefix: | ptct_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition. + References No definition available. + Details
Name: | us-gaap_FinitelivedIntangibleAssetsAcquired1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_CounterpartyNameAxis=ptct_MarathonPharmaceuticalsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |